Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2025-12-24 @ 1:18 PM
NCT ID:
NCT06717295
Eligibility Criteria:
Phase 1 (Common Cancer Early Detection - CCANED)
Inclusion Criteria:
* Age: Adults aged 40 years or older.
* Confirmed diagnosis of one of the following common cancers: Non-Small Cell Lung Cancer (NSCLC), Glioblastoma Multiforme (GBM), Colorectal Cancer, Hepatocellular Carcinoma (HCC), Breast Cancer, Prostate Cancer, Ovarian Cancer, Pancreatic Cancer.
Exclusion Criteria:
* Currently pregnant.
* Presence of any active infectious diseases.
* Use of anticoagulant or antiplatelet drugs within the past 2 weeks.
* Any medical or psychological conditions that may affect the participant's ability to comply with study procedures.
Phase 2 ( Cancer Immuno-Profiling of Hematologic and Extracellular RNA - CIPHER)
Inclusion Criteria:
* Adults aged 40 years or older.
* Confirmed diagnosis of: Hepatocellular Carcinoma (HCC), Non-Small Cell Lung Cancer (NSCLC)
* Willingness to provide blood samples at the specified intervals (baseline, 6 weeks, and 6 months post-therapy initiation).
Exclusion Criteria:
* Presence of another malignancy unless it has been in remission for at least 5 years.
* Significant uncontrolled co-morbid conditions that may interfere with study participation or outcomes.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
75 Years
Study:
NCT06717295
Study Brief:
Protocol Section:
NCT06717295